Kuck, Dirk <br/><br/>
Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells.  [electronic resource] 

 -  Molecular cancer therapeutics  Nov 2010 
 - 3015-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-10-0609  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>DNA (Cytosine-5-)-Methyltransferases--antagonists & inhibitors<br/>DNA Methylation--drug effects<br/>Drug Evaluation, Preclinical<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Silencing--drug effects<br/>Genes, Tumor Suppressor--drug effects<br/>HCT116 Cells<br/>HL-60 Cells<br/>HeLa Cells<br/>Humans<br/>Inhibitory Concentration 50<br/>Models, Biological<br/>Naphthoquinones--pharmacology<br/>Neoplasms--genetics<br/>Substrate Specificity<br/>Transcriptional Activation--drug effects<br/>Tumor Cells, Cultured<br/>DNA Methyltransferase 3B